Inari Medical (NARI)
(Delayed Data from NSDQ)
$44.38 USD
+0.28 (0.63%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $44.37 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for Inari Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -1.64 | -29.27 | 9.84 | 13.79 | -1.19 |
Depreciation/Amortization & Depletion | -2.50 | 7.26 | 4.45 | 1.57 | 0.73 |
Net Change from Assets/Liabilities | 2.64 | -21.47 | -14.30 | -21.17 | -6.32 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 37.42 | 29.50 | 25.50 | 7.73 | 1.85 |
Net Cash From Operating Activities | 35.93 | -13.97 | 25.49 | 1.91 | -4.94 |
Property & Equipment | -6.20 | -9.95 | -13.65 | -5.46 | -3.14 |
Acquisition/ Disposition of Subsidiaries | -240.42 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 188.60 | -185.27 | -37.38 | -49.98 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -58.02 | -195.22 | -51.02 | -55.44 | -3.14 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 10.75 | 183.63 | 6.43 | 164.83 | 0.13 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | -20.25 | 9.86 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -9.57 | -6.49 | -2.35 | -0.47 | 0.24 |
Net Cash from Financing Activities | 1.17 | 177.14 | 4.07 | 144.12 | 10.22 |
Effect of Exchange Rate Changes | -0.09 | -0.48 | -0.40 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -21.01 | -32.53 | -21.87 | 90.59 | 2.14 |
Cash at Beginning of Period | 60.22 | 92.75 | 114.62 | 24.03 | 21.88 |
Cash at End of Period | 39.21 | 60.22 | 92.75 | 114.62 | 24.03 |
Diluted Net EPS | -0.03 | -0.55 | 0.18 | 0.27 | NA |
Fiscal Year End for Inari Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -55.55 | -24.20 | -1.64 | 3.03 | -0.13 |
Depreciation/Amortization & Depletion | 8.43 | 4.09 | -2.50 | -4.09 | -2.98 |
Net Change from Assets/Liabilities | 7.67 | -11.35 | 2.64 | -6.90 | -9.93 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 38.67 | 19.18 | 37.42 | 31.65 | 20.79 |
Net Cash From Operating Activities | -0.78 | -12.29 | 35.93 | 23.69 | 7.75 |
Property & Equipment | -6.49 | -1.91 | -6.20 | -3.80 | -2.19 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -240.42 | 0.00 | 0.00 |
Investments | 36.17 | 41.07 | 188.60 | 5.50 | -7.93 |
Other Investing Activities | 3.72 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 33.40 | 39.16 | -58.02 | 1.70 | -10.12 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.23 | 4.13 | 10.75 | 10.47 | 4.61 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -5.96 | -3.11 | -9.57 | -6.89 | -4.50 |
Net Cash from Financing Activities | -1.74 | 1.02 | 1.17 | 3.58 | 0.11 |
Effect of Exchange Rate Changes | 0.10 | 0.11 | -0.09 | -0.01 | -0.12 |
Net Change In Cash & Equivalents | 30.98 | 28.00 | -21.01 | 28.96 | -2.39 |
Cash at Beginning of Period | 39.21 | 39.21 | 60.22 | 60.22 | 60.22 |
Cash at End of Period | 70.19 | 67.21 | 39.21 | 89.18 | 57.84 |
Diluted Net EPS | -0.54 | -0.42 | -0.08 | 0.05 | 0.04 |